Was Jim Cramer Right About These 23 Stocks?

Page 8 of 23

16. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 115

Eli Lilly and Company (NYSE:LLY) is a global pharmaceutical leader. In that older episode, Cramer noted Eli Lilly as a key player in the booming GLP-1 market.

“Lilly’s been part of the great broadening for a while now thanks to this revolutionary GLP-1 drug for weight loss and diabetes […] Lilly’s Zepbound, which is their weight loss version of the GLP-1, is in extremely short supply all around the nation.”

Eli Lilly and Company (NYSE:LLY) has climbed by 8.03% since Cramer highlighted it.

On the 11th of March, Cramer asserted his opinion that Eli Lilly and Company (NYSE:LLY) is among the top 10 US companies:

“Remember Lilly passed Tesla, that’s why remember the Magnificent 7 is the Okay 10 because I don’t have seven.”

Page 8 of 23